• NEWS

    Read the Latest News From NewBridge 

  • 1
Press Release

NewBridge Pharmaceuticals at EASL 2019

NewBridge Pharmaceuticals at WCO-IOF-ESCEO Paris 2019
Sunovion Pharmaceuticals Europe Ltd. and NewBridge Pharmaceuticals Announce Agreement for Distribution of Latuda® (lurasidone) in the Gulf Cooperation Council Region

NewBridge President and CEO Joe Henein, Business Director Group Franchise Hisham EL Sayed and Brand Manager Rare Diseases Jennifer Bteich, attended The International Liver Congress “EASL 2019”, that was held in Vienna-Austria from April 10-14th along with Intercept team.

This year, EASL witnessed one of the most exciting and biggest study about NASH (Non-Alcoholic Steatohepatitis) that was presented for the first time during the congress.

NewBridge Pharmaceuticals at WCO-IOF-ESCEO Paris 2019
Sunovion Pharmaceuticals Europe Ltd. and NewBridge Pharmaceuticals Announce Agreement for Distribution of Latuda® (lurasidone) in the Gulf Cooperation Council Region